Clover Health Investments price to free cash flow CLOV
Market value divided by free cash flow over the last twelve months, since 2023.
- Today, Nov 2, 2026
- 30.8×
- 3-year median
- 33.5×
- Against its 3-year history
- 27th
- percentile: 0 is its lowest day, 100 its highest
- 3-year range
- 22.4× to 57.1×
- Peer median
- 16.4×
Clover Health Investments' price to free cash flow is 30.8× as of Nov 2, 2026.
That is below its 3-year median of 33.5×, lower than on 73% of days in the last 3 years.
Over that time it ranged from 22.4× in Oct 2023 to 57.1× in Mar 2025.
The median for 3 health insurers of a similar size is 16.4×.
Price to free cash flow over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 30.8× | 29.7× | 52.2× |
| 2025 | 51.3× | 51.1× | 57.1× |
| 2024 | n/m a value too high to mean anything | ||
| 2023 | 26.8× | 22.4× | 36.8× |
Against its peers
Companies in Medical - Healthcare Plans nearest Clover Health Investments' size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| CLOVClover Health Investments | 30.8× |
| ALHCAlignment Healthcare | 19.0× |
| TRUPTrupanion | 16.4× |
| OSCROscar Health | 2.2× |
| Peer median | 16.4× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Clover Health Investments
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.